XML 19 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net income (loss) $ 136,165 $ 486,278
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization of real estate, in-place lease and other intangibles: 286,542 267,305
Amortization of deferred compensation 10,218 7,092
Amortization of deferred financing costs 6,690 7,702
Straight-line rents (16,479) (8,176)
Equity loss (income) from unconsolidated joint ventures (469) (3,509)
Distributions of earnings from unconsolidated joint ventures 13,911 18,528
Deferred income tax expense (benefit) (7,388) (12,472)
Impairments (recoveries), net 13,912 56,682
Loss (gain) on sales of real estate, net (66,879) (317,670)
Loss (gain) on consolidation, net 41,017 0
Loss (gain) on sale of marketable securities 0 (50,895)
Other non-cash items (3,367) (2,323)
Decrease (increase) in accounts receivable and other assets, net (8,444) (8,777)
Increase (decrease) in accounts payable and accrued liabilities 34,245 (8,176)
Net cash provided by (used in) operating activities 439,674 431,589
Cash flows from investing activities:    
Acquisitions of real estate (23,087) (26,446)
Development and redevelopment of real estate (229,831) (157,898)
Leasing costs, tenant improvements, and recurring capital expenditures (45,591) (48,575)
Proceeds from sales of real estate, net 319,224 1,235,851
Contributions to unconsolidated joint ventures (6,053) (21,302)
Distributions in excess of earnings from unconsolidated joint ventures 15,344 1,609
Proceeds from the RIDEA II transaction, net 335,709 462,242
Proceeds from sales/principal repayments on debt investments and direct financing leases 132,429 549,759
Investments in loans receivable, direct financing leases and other (6,376) (18,433)
Net cash provided by (used in) investing activities 491,768 1,976,807
Cash flows from financing activities:    
Borrowings under bank line of credit, net 453,000 (441,581)
Repayments under bank line of credit (923,164) (339,826)
Issuance and borrowings of debt, excluding bank line of credit 0 5,395
Repayments and repurchase of debt, excluding bank line of credit (2,856) (966,126)
Issuance of common stock and exercise of options 3,433 13,887
Repurchase of common stock (2,778) (4,361)
Dividends paid on common stock (348,439) (347,118)
Issuance of noncontrolling interests 995 650
Distributions to and purchase of noncontrolling interests (71,931) (13,087)
Net cash provided by (used in) financing activities (891,740) (2,092,167)
Effect of foreign exchanges on cash, cash equivalents and restricted cash 24 227
Net increase (decrease) in cash, cash equivalents and restricted cash 39,726 316,456
Cash, cash equivalents and restricted cash, beginning of period 82,203 136,990
Cash, cash equivalents and restricted cash, end of period $ 121,929 $ 453,446